warnings
WARNINGS Anaphylactogenesis may occur with parenteral thiamine. Use with caution. An intradermal test dose is recommended prior to administration in patients suspected of being sensitive to the drug.
Vitamin B Complex
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Vitamin B Complex
- Generic name
- THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE
- Manufacturer
- Mylan Institutional LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 282ccec8-9bcd-4571-9b91-bbb96ef2620d
- SPL ID
- a7704aa3-bd3d-479e-8469-767d59636c7e
- Version
- 8
- Effective date
- 2021-09-15
- Source export date
- 2026-09-28
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:28:02
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Vitamin B Complex | openfda.brand_name | |
| generic name | THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE | openfda.generic_name | |
| manufacturer name | Mylan Institutional LLC | openfda.manufacturer_name | |
| ndc | package | 67457-146-30 | openfda.package_ndc |
| ndc | product | 67457-146 | openfda.product_ndc |
| ndc11 | package | 67457014630 | derived:openfda.package_ndc |
| rxcui | 801177 | openfda.rxcui | |
| spl id | a7704aa3-bd3d-479e-8469-767d59636c7e | id | |
| spl set id | 282ccec8-9bcd-4571-9b91-bbb96ef2620d | set_id | |
| unii | 1O6C93RI7Z | openfda.unii | |
| unii | 25X51I8RD4 | openfda.unii | |
| unii | 20RD1DZH99 | openfda.unii | |
| unii | M572600E5P | openfda.unii | |
| unii | 68Y4CF58BV | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Mild transient diarrhea, polycythemia vera, peripheral vascular thrombosis, itching transitory exanthema, feeling of swelling of entire body, anaphylactic shock and death. Sensitivity to the ingredients listed may occur (see WARNINGS ). Use should be discontinued upon observance of any untoward reaction. Pain upon intramuscular injection may be noted.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.